Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
Avedro, Inc., an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling, today announced that it has begun enrolling patients in a pivotal Phase 3 clinical trial to evaluate the safety and efficacy of an epithelium-on (epi-on) corneal collagen cross-linking procedure to treat patients with progressive keratoconus. Keratoconus is a non-inflammatory eye condition in which the typically round dome-shaped cornea progressively thins and weakens and is the leading cause of penetrating keratoplasty (corneal transplant) in the United States1.
The Phase 3 clinical trial, ACP-KXL-308, is a multicenter, randomized, controlled study of a novel corneal cross-linking procedure of 275 patients with progressive keratoconus across approximately 20 sites in the United States. As is typical for U.S. Food and Drug Administration (FDA) drug trials, investigational treatments are provided at no cost to participating patients.
“As a practitioner who has treated many patients with progressive keratoconus in previous clinical studies, the commencement of this epi-on cross-linking study represents another important milestone. This procedure, designed to eliminate the need to remove the epithelium, has the potential to be of great value to patients and practices alike,” said Michael B. Raizman, MD, clinical investigator and practicing ophthalmologist at Ophthalmic Consultants of Boston.
“Since the 2016 FDA approval of Avedro’s epi-off cross-linking treatment, thousands of patients with progressive keratoconus, a potentially debilitating disease, have benefited from this procedure,” said Rajesh K. Rajpal, MD, Chief Medical Officer for Avedro and Founder of See Clearly Vision in the Washington D.C. area. “We are proud to continue our efforts to serve these patients and the doctors who treat them with this trial, which is the first and only epi-on study currently intended to support an FDA approval filing.”
“The start of this study is exciting news for patients,” said Mary Prudden, Program Director, National Keratoconus Foundation. “We are pleased to see continued innovation in corneal cross-linking technologies and are hopeful that this research will ultimately lead to a second FDA-approved option for patients living with this rare and sight-threatening condition.”
The current list of participating study sites include Massachusetts, Ohio, Utah, Pennsylvania and Virginia. As new sites are initiated, they will be listed on clinicaltrials.gov.
Avedro is a privately held pharmaceutical and medical device company and the world leader in corneal remodeling. Our patented cross-linking technology, consisting of drug formulations and medical devices, are approved for sale in numerous countries around the globe. We continue to develop proprietary corneal remodeling products for the treatment of keratoconus, corneal ectasia and for refractive correction as an alternative to contacts and eyeglasses. Keratoconus and corneal ectasia are rare and sight-threatening eye conditions in which the cornea progressively thins and weakens causing the development of a cone-like bulge and optical irregularity of the cornea which can result in significant visual impairment.
At Avedro, our mission is to produce and deliver innovative, minimally invasive drugs and devices for corneal remodeling to eyecare professionals around the world to improve patients’ vision and quality of life. For more information, visit www.Avedro.com.
- Borderie VM, Boelle PY, Touzeau O, et al. Predicted long-term Outcome of corneal transplantation. Ophthalmology 2009;2354-2360 Eye Bank Association of America Statistical Report, 2016
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
H.I.G. Europe to Acquire Polyurethane Systems Business from Covestro17.6.2019 08:05:00 CEST | Pressemelding
H.I.G. Capital, LLC ("H.I.G."), a leading global private equity investment firm with over €26 billion of equity capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire the European Polyurethane Systems Business (the “Company”) in a carve-out transaction from Covestro AG. The transaction is subject to clearing by the relevant antitrust authorities with closing anticipated for the second half of 2019. The European Polyurethane Systems Business operates four systems houses in Germany, Denmark, the Netherlands and Spain. It employs approximately 250 full-time employees and generates annual sales of approximately €230 million. Systems houses develop and formulate tailor-made ready-to-use chemical blends for the production of a wide range of polyurethane products such as insulation materials, foams, shoe soles, and building materials. The Company serves a wide range of small- and mid-sized customers across Europe and will be led by Dr.
Norsk Titanium Announces Larger Capacity Rapid Plasma Deposition™ (RPD™) Machine17.6.2019 08:00:00 CEST | Pressemelding
Officials with Norsk Titanium (Norsk) announced today the company has designed and is currently building a larger-scale Rapid Plasma Deposition™ (RPD™) machine. This new machine enables manufacturing of larger, more complex aircraft and engine components, at faster print speeds. The new RPD™ machine, the G-IVL, will use the same advanced RPD™ technology of Norsk’s current additive manufacturing process. Norsk’s patented RPD™ technology and equipment utilizes proprietary process controls to melt titanium wire with plasma torches, in an argon environment to produce near-net shape components for airframe and aircraft engine applications. The Norsk G-IVL machine will expand the printing envelope to 190cm by 40cm by 60cm. It will print double-sided, as well as single-sided components, of complex geometries and deposit material in excess of 8kg per hour. The resultant component will have the material qualities equivalent to forgings. “The G-IVL machine will significantly expand Norsk’s capab
TYAN Powers AI and HPC with 2nd Gen Intel® Xeon® Scalable Processor-based Server Platforms at ISC 201917.6.2019 08:00:00 CEST | Pressemelding
TYAN®, an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, is showcasing its new 2nd gen Intel® Xeon® Scalable processor-based platforms that are optimized for predictive analytics, machine learning, and HPC applications at ISC 2019 from June 17-19 at Messe Frankfurt, booth C-1250. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005020/en/ TYAN's Thunder HX Lineup Designed for AI Optimization and HPC Revolution (Photo: Business Wire) “The most demanding workloads including HPC, AI deep learning, data analytics, and multi-cloud infrastructure require maximum performance across compute, memory, storage, and network resources, “said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “2nd gen Intel Xeon Scalable processors provide a powerful foundation for TYAN server platforms that enables us to deliver performance enhanceme
Appointment of Mark Wood as Chairman of HomeServe Labs17.6.2019 08:00:00 CEST | Pressemelding
HomeServe plc (“HomeServe”, “the Group”), the international home repairs and improvements business, is pleased to announce the appointment of Mark Wood CBE as non-Executive Chairman of HomeServe Labs, the unit within HomeServe that developed LeakBot. HomeServe Labs is the innovation arm of HomeServe which in 2016 launched LeakBot, a patented smart leak alarm that can detect leaks anywhere on a mains water system. Water leaks are one of the major causes of claims on home insurance policies across Western Europe and the US, and LeakBot is designed specifically to help insurance companies prevent water leak claims by catching the leaks early. Craig Foster, LeakBot CEO, said: "Mark Wood is a previous CEO of AXA and a veteran of the insurance industry. This experience will really benefit us as a B2B Insuretech. Mark is also a successful entrepreneur himself, and more recently added a huge amount of value to promising fintech start-ups like PensionBee. With Mark on board as our new Chairman,
L&T Technology Services Successfully Concludes Its Engineering The Change Campaign in Europe with 24-Hour Hackathon17.6.2019 07:30:00 CEST | Pressemelding
L&T Technology Services Limited (NSE: LTTS), a leading global pure-play engineering services company, successfully concluded its Engineering the Change campaign in Munich with a 24-hour hackathon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005290/en/ Caption - Left to right: Nitin Ugale from Sulzer | Gaurav Gupta from LTTS | Winners - Annabel Michel; Lars Konig; Atenea Fernandez Rozaoilla; Luca Setili; Till Neumeier | David Humphrey from ARC Advisory Group | Samir Bagga from LTTS | Nawida Martinozzi from Nokia (Photo: Business Wire) The company’s 16-day pan Europe initiative included a 3,000 km innovation-on-wheels drive covering Greater Manchester & Ellesmere Port (Cheshire) in the UK, Amiens & Paris in France and Eindhoven in Netherlands, culminating in Germany. A total of 230 visitors, including customers, analysts, industry experts, government officials, local authorities and engineering students attended the d
Philip Morris International Holds ‘Open Mic’ at 2019 Cannes Lions Festival17.6.2019 07:00:00 CEST | Pressemelding
Philip Morris International (PMI) (NYSE: PM) announced today its return to the Cannes Lions International Festival of Creativity to engage with those who are actively creating and shaping meaningful change in the world. Working from its central theme of “Open Mic,” PMI will foster conversations around unexpected and provocative ideas, concepts and views with some of today’s boldest thinkers at the gathering known for bringing together the world’s most creative people to discuss new ideas, pioneering research and emerging technologies that help make and shape popular culture. “For PMI, attending Cannes is a surprising juxtaposition of what people may expect of us. But that’s what we need to do as we strive to unsmoke the world: be bold, cut through the haze and have conversations about the future,” said Jacek Olczak, chief operating officer for PMI. Returning to Cannes for the second year in a row, PMI will host a series of panels, one-on-one conversations and events that focus on encou